Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination
- PMID: 25326638
- PMCID: PMC4207860
- DOI: 10.1093/jnci/dju284
Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination
Abstract
Background: Computed tomography (CT) screening for lung cancer has been associated with a high frequency of false positive results because of the high prevalence of indeterminate but usually benign small pulmonary nodules. The acceptability of reducing false-positive rates and diagnostic evaluations by increasing the nodule size threshold for a positive screen depends on the projected balance between benefits and risks.
Methods: We examined data from the National Lung Screening Trial (NLST) to estimate screening CT performance and outcomes for scans with nodules above the 4mm NLST threshold used to classify a CT screen as positive. Outcomes assessed included screening results, subsequent diagnostic tests performed, lung cancer histology and stage distribution, and lung cancer mortality. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated for the different nodule size thresholds. All statistical tests were two-sided.
Results: In 64% of positive screens (11598/18141), the largest nodule was 7 mm or less in greatest transverse diameter. By increasing the threshold, the percentages of lung cancer diagnoses that would have been missed or delayed and false positives that would have been avoided progressively increased, for example from 1.0% and 15.8% at a 5 mm threshold to 10.5% and 65.8% at an 8 mm threshold, respectively. The projected reductions in postscreening follow-up CT scans and invasive procedures also increased as the threshold was raised. Differences across nodules sizes for lung cancer histology and stage distribution were small but statistically significant. There were no differences across nodule sizes in survival or mortality.
Conclusion: Raising the nodule size threshold for a positive screen would substantially reduce false-positive CT screenings and medical resource utilization with a variable impact on screening outcomes.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Figures
Comment in
-
Nodule size and overdiagnosis in lung cancer CT screening.J Natl Cancer Inst. 2014 Oct 18;106(11):dju325. doi: 10.1093/jnci/dju325. Print 2014 Nov. J Natl Cancer Inst. 2014. PMID: 25326639 No abstract available.
References
-
- Swensen SJ, Jett JR, Hartman TE, et al. Lung cancer screening with ct: Mayo clinic experience. Radiology. 2003;226(3):756–761 - PubMed
-
- Henschke CI, Yip R, Yankelevitz DF, Smith JP. Definition of a positive test result in computed tomography screening for lung cancer: A cohort study. Ann Intern Med. 2013;158(4):246–252 - PubMed
-
- MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on ct scans: A statement from the fleischner society. Radiology. 2005;237(2):395–400 - PubMed
Publication types
MeSH terms
Grants and funding
- N01-CN-25524/CN/NCI NIH HHS/United States
- N01-CN-25513/CN/NCI NIH HHS/United States
- N01-CN-75022/CN/NCI NIH HHS/United States
- N01-CN-25514/CN/NCI NIH HHS/United States
- N01 CN025511/CA/NCI NIH HHS/United States
- N01-CN-25515/CN/NCI NIH HHS/United States
- N01 CN075022/CA/NCI NIH HHS/United States
- N02 CN063300/CA/NCI NIH HHS/United States
- U01 CA079778/CA/NCI NIH HHS/United States
- N01 CN025518/CA/NCI NIH HHS/United States
- N01-CN-25516/CN/NCI NIH HHS/United States
- N01 CN025515/CA/NCI NIH HHS/United States
- U10 CA180794/CA/NCI NIH HHS/United States
- N01-CN-25522/CN/NCI NIH HHS/United States
- N01-CN-25511/CN/NCI NIH HHS/United States
- N01 CN025512/CA/NCI NIH HHS/United States
- CA79778/CA/NCI NIH HHS/United States
- U01 CA080098/CA/NCI NIH HHS/United States
- N01-CN-25512/CN/NCI NIH HHS/United States
- N01 CN025522/CA/NCI NIH HHS/United States
- N01 CN025513/CA/NCI NIH HHS/United States
- N01 CN025524/CA/NCI NIH HHS/United States
- N01 CN025476/CA/NCI NIH HHS/United States
- N02-CN-63300/CN/NCI NIH HHS/United States
- N01 CN025516/CA/NCI NIH HHS/United States
- UG1 CA189828/CA/NCI NIH HHS/United States
- U01-CA-80098/CA/NCI NIH HHS/United States
- U10 CA180820/CA/NCI NIH HHS/United States
- N01-CN-25476/CN/NCI NIH HHS/United States
- N01-CN-25518/CN/NCI NIH HHS/United States
- N01 CN025514/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
